Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen concentrator (“POC”) space. The optimism, led by solid first-quarter 2025 ...
Inogen, Inc. INGN has witnessed strong momentum in the past six months period. Shares of the company have surged 46.8% compared with 1.8% growth of the industry. The S&P 500 composite has risen 10% ...
Inogen stock got crushed in the tech rout, giving investors a second bite at the apple. Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more.
Q4 2025 earnings call recap: revenue growth, 2026 guidance, Simeox & CPAP expansion, margins, and $30M buyback—read key takeaways.
This article first appeared on GuruFocus. Inogen Inc (NASDAQ:INGN) is set to release its Q3 2025 earnings on Nov 5, 2025. The consensus estimate for Q3 2025 revenue is $92.20 million, and the earnings ...
Q4 2025 Earnings Call February 24, 2026 5:00 PM ESTCompany ParticipantsLorna Williams - Senior Vice President of Investor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results